Benjamin Hébraud

1.7k total citations
24 papers, 506 citations indexed

About

Benjamin Hébraud is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Benjamin Hébraud has authored 24 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Benjamin Hébraud's work include Multiple Myeloma Research and Treatments (17 papers), Protein Degradation and Inhibitors (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Benjamin Hébraud is often cited by papers focused on Multiple Myeloma Research and Treatments (17 papers), Protein Degradation and Inhibitors (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Benjamin Hébraud collaborates with scholars based in France, United States and Spain. Benjamin Hébraud's co-authors include Jill Corre, Philippe Bourin, Michel Attal, Murielle Roussel, Hervé Avet‐Loiseau, Philippe Moreau, Nicolas Espagnolle, Mélanie Gadelorge, Xavier Leleu and Thierry Façon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Benjamin Hébraud

23 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Hébraud France 9 218 194 166 132 125 24 506
Les Coulton United Kingdom 15 292 1.3× 187 1.0× 70 0.4× 263 2.0× 58 0.5× 22 761
Sandrine Hayette France 16 164 0.8× 329 1.7× 168 1.0× 63 0.5× 175 1.4× 33 696
Amanda K. Ombrello United States 15 341 1.6× 151 0.8× 283 1.7× 113 0.9× 52 0.4× 34 934
Justyna Rak France 11 184 0.8× 191 1.0× 57 0.3× 40 0.3× 35 0.3× 19 531
B. Vitolo Italy 12 111 0.5× 90 0.5× 396 2.4× 157 1.2× 30 0.2× 20 727
Bingyu Shi China 12 158 0.7× 50 0.3× 58 0.3× 68 0.5× 63 0.5× 18 444
Silvia Haffner Germany 9 202 0.9× 117 0.6× 45 0.3× 76 0.6× 28 0.2× 12 530
Helen Koutala Greece 9 67 0.3× 78 0.4× 88 0.5× 94 0.7× 46 0.4× 12 452
Ariane Hammitzsch Germany 11 316 1.4× 212 1.1× 371 2.2× 97 0.7× 27 0.2× 18 816
Jerzy Supronik United States 6 119 0.5× 165 0.9× 360 2.2× 196 1.5× 31 0.2× 11 707

Countries citing papers authored by Benjamin Hébraud

Since Specialization
Citations

This map shows the geographic impact of Benjamin Hébraud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Hébraud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Hébraud more than expected).

Fields of papers citing papers by Benjamin Hébraud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Hébraud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Hébraud. The network helps show where Benjamin Hébraud may publish in the future.

Co-authorship network of co-authors of Benjamin Hébraud

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Hébraud. A scholar is included among the top collaborators of Benjamin Hébraud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Hébraud. Benjamin Hébraud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wyngaert, Zoé Van de, Florent Malard, Cyrille Hulin, et al.. (2023). Non-interventional Study Evaluating the Mobilization of Stem Cells by Plerixafor Before Salvage Autologous Stem Cell Transplant in Relapsed Multiple Myeloma (IFM-2015-03). SHILAP Revista de lepidopterología. 5(1). 38–42. 1 indexed citations
2.
3.
Hébraud, Benjamin, Pierre‐Luc Mouchel, Pierre Bories, et al.. (2023). French Monocentric Experience of Outpatient Step-up Dosing of Teclistamab in Relapsed Refractory Multiple Myeloma. Blood. 142(Supplement 1). 4736–4736. 3 indexed citations
4.
5.
Espagnolle, Nicolas, Benjamin Hébraud, Mélanie Gadelorge, et al.. (2020). Functional Comparison between Healthy and Multiple Myeloma Adipose Stromal Cells. Stem Cells International. 2020. 1–9. 6 indexed citations
6.
Roussel, Murielle, Benjamin Hébraud, Cyrille Hulin, et al.. (2020). Health-related quality of life results from the IFM 2009 trial: treatment with lenalidomide, bortezomib, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma. Leukemia & lymphoma. 61(6). 1323–1333. 24 indexed citations
7.
Menard, Cédric, Joëlle Dulong, David Roulois, et al.. (2019). Integrated transcriptomic, phenotypic, and functional study reveals tissue-specific immune properties of mesenchymal stromal cells. Stem Cells. 38(1). 146–159. 60 indexed citations
8.
9.
10.
Rosiñol, Laura, Benjamin Hébraud, Albert Oriol, et al.. (2019). Integrated Analysis of Bortezomib-Lenalidomide-Dexamethasone vs Bortezomib-Thalidomide-Dexamethasone in Transplant-Eligible Newly Diagnosed Myeloma. Clinical Lymphoma Myeloma & Leukemia. 19(10). e1–e2. 5 indexed citations
11.
Mazzotti, Céline, Laure Buisson, Sabrina Mahéo, et al.. (2018). Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow. Blood Advances. 2(21). 2811–2813. 71 indexed citations
12.
13.
Ruyssen‐Witrand, Adeline, Yannick Degboé, Isabelle Gennero, et al.. (2017). DKK1 and sclerostin are early markers of relapse in multiple myeloma. Bone. 113. 114–117. 15 indexed citations
14.
Evans, Neil D., Bertrand Arnulf, Hervé Avet‐Loiseau, et al.. (2017). Analysis of a Compartmental Model of Endogenous Immunoglobulin G Metabolism with Application to Multiple Myeloma. Frontiers in Physiology. 8. 149–149. 15 indexed citations
15.
Jaccard, Arnaud, Lionel Karlin, Sylvain Choquet, et al.. (2015). A Prospective Phase II Trial of Lenalidomide and Dexamethasone (Len-Dex) in POEMS Syndrome. Clinical Lymphoma Myeloma & Leukemia. 15. e57–e57. 6 indexed citations
16.
Obéric, Lucie, Benjamin Hébraud, Christian Récher, et al.. (2014). Clinical activity of a new regimen combining gemcitabine and alemtuzumab in high‐risk relapsed/refractory chronic lymphocytic leukemia patients. European Journal Of Haematology. 94(1). 37–42. 6 indexed citations
17.
Corre, Jill, Benjamin Hébraud, Florence Magrangeas, et al.. (2014). in Multiple Myeloma, High-Risk Features Are Modulated By Other Chromosomal changes : A Large Snparray IFM Study. Blood. 124(21). 641–641. 1 indexed citations
18.
Corre, Jill, Benjamin Hébraud, & Philippe Bourin. (2013). Concise Review: Growth Differentiation Factor 15 in Pathology: A Clinical Role?. Stem Cells Translational Medicine. 2(12). 946–952. 158 indexed citations
19.
Corre, Jill, Nicolas Espagnolle, Benjamin Hébraud, et al.. (2012). Bioactivity and Prognostic Significance of Growth Differentiation Factor GDF15 Secreted by Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma. Cancer Research. 72(6). 1395–1406. 76 indexed citations
20.
Hébraud, Benjamin, et al.. (2008). Unusual presentation of primary toxoplasmosis infection in a kidney-transplant patient complicated by an acute left-ventricular failure. Clinical Kidney Journal. 1(6). 429–432. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Les Coulton Breakdown of academic impact, for papers by Sandrine Hayette Breakdown of academic impact, for papers by Amanda K. Ombrello Breakdown of academic impact, for papers by Justyna Rak Breakdown of academic impact, for papers by B. Vitolo Breakdown of academic impact, for papers by Bingyu Shi Breakdown of academic impact, for papers by Silvia Haffner Breakdown of academic impact, for papers by Helen Koutala Breakdown of academic impact, for papers by Ariane Hammitzsch Breakdown of academic impact, for papers by Jerzy Supronik
Rankless by CCL
2026